Medical Marijuana for Epilepsy in Florida
A neurological disorder causing recurrent seizures, with cannabis showing strong evidence for reduction.
Medically reviewed by Bruce Stratt, MD
Board-Certified Physician · OMMU Certified · Boca Raton, FL
Overview
Epilepsy is a neurological disorder characterized by recurrent, unprovoked seizures resulting from abnormal electrical activity in the brain — essentially a massive activation of brain cells all at once. It affects approximately 3.4 million people in the United States and can manifest in many forms, including absence seizures (brief lapses of consciousness), tonic seizures (muscle stiffness), clonic seizures (repetitive jerking), and tonic-clonic seizures (the most severe, involving loss of consciousness and convulsions).
While anti-epileptic drugs (AEDs) control seizures in many patients, approximately 30% have refractory epilepsy — meaning their seizures are not adequately controlled by medication. Current pharmaceutical treatments can also carry serious side effects including bone density loss, memory impairment, and vision problems. For patients with treatment-resistant seizures, medical cannabis has emerged as a compelling therapeutic option with the strongest clinical evidence base of any cannabis application.
Florida explicitly lists epilepsy as a qualifying condition under Statute 381.986, and the state was among the early adopters of low-THC cannabis access specifically for epilepsy patients. The Charlotte's Web movement — named after Charlotte Figi, a young girl with Dravet syndrome whose seizures were dramatically reduced by CBD-rich cannabis — played a significant role in shaping Florida's compassionate use legislation. Today, Florida epilepsy patients have access to a full range of cannabis products, including high-CBD formulations specifically suited to seizure management.
How Medical Cannabis May Help
CBD (cannabidiol) has the strongest evidence base for seizure reduction among all medical cannabis applications. The FDA-approved CBD medication Epidiolex demonstrated significant seizure reduction in landmark clinical trials for Dravet syndrome and Lennox-Gastaut syndrome — two of the most severe and treatment-resistant forms of epilepsy. Multiple studies show CBD can reduce seizure frequency by 50% or more in treatment-resistant patients, and some patients achieve near-complete seizure freedom. CBD acts as a neuroprotectant through multiple mechanisms — it modulates GPR55 receptors, activates TRPV1 vanilloid channels, and blocks sodium channels, all of which contribute to stabilizing neuronal excitability. CBD also competes with the body's endocannabinoids for reuptake, elevating their levels in neural synapses, which appears to play a direct role in reducing seizure activity. Importantly, CBD is nonpsychoactive, and studies show that even in high dosages there are no signs of toxicity, with side effects being extremely rare and minor. Medical cannabis also improves quality of life and alertness in some patients compared to high-dose AED regimens, which often cause debilitating drowsiness and cognitive impairment. For patients whose seizures are not adequately controlled by conventional medications, cannabis — particularly CBD-dominant formulations — offers a well-supported complementary approach. Dr. Stratt evaluates each epilepsy patient's seizure type, frequency, current medications, and treatment history to develop an appropriate cannabis recommendation that works alongside their neurologist's care plan.
Individual results vary. Consult with Dr. Stratt to understand how cannabis therapy may apply to your specific situation.
What to Bring to Your Appointment
Bring a valid Florida ID, neurology records documenting your epilepsy diagnosis, a list of current anti-epileptic medications and their dosages, and any seizure diary or frequency records.
Frequently Asked Questions
Related Articles
Patient Resources
Get Your Medical Marijuana Card for Epilepsy
Schedule your evaluation with Dr. Stratt. Same-day state registry submissions for qualifying patients.